Healthcare
Live Price
Offline$84.12
+0.00% today
1Y Change
-12.55%
Window
Jun 23, 2025 → Jun 12, 2026
Coverage: 245 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Siegfried Holding AG (SGFEF) is a Healthcare stock with a market cap of $3.45B and listed on OTC. The stock last traded around $84.12 and down 12.5% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of +2.6%, EPS growth of +3.8%, a dividend yield of 0.5%. What stands out right now is revenue +2.6%, EPS +3.8%, free cash flow +182.7% with operating margin 15.7% and ROIC 9.2%. The dividend is present but secondary, with a yield around 0.5%. Valuation is more restrained than many high-expectation growth names at P/E 20.4 and price/sales 2.6. Stock Foundry combines SGFEF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SGFEF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SGFEF Max Drawdown
-12.55%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SGFEF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$1.1B
-10.3% YoY
FY Net Income
$95.6M
-38.9% YoY
Free Cash Flow
$6.4M
-76.6% YoY
Revenue Growth
+2.6%
EPS Growth
+3.8%
Gross Margin
26.7%
Net Margin
12.7%
Income statement
CHF
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.3B | 1.3B | 1.3B | 1.2B | 1.1B |
| Gross Profit | 353M | 329M | 320M | 319M | 240M |
| Operating Income | 210M | 199M | 172M | 231M | 132M |
| EBITDA | 307M | 289M | 241M | 308M | 213M |
| Net Income | 169M | 160M | 113M | 156M | 96M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
CHF
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 103M | 39M | 56M | 91M | 73M |
| Total Assets | 2.2B | 1.9B | 1.9B | 1.8B | 1.7B |
| Total Liabilities | 1.0B | 954M | 1.0B | 1.0B | 981M |
| Shareholder Equity | 1.1B | 980M | 838M | 791M | 688M |
| Total Debt | 575M | 490M | 525M | 590M | 560M |
| Net Debt | 472M | -39M | 469M | 499M | 487M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
120M
-15.9% YoY
Capital Expenditures
113M
+1.6% YoY
Free Cash Flow
6M
-76.6% YoY
Key ratios
Gross Margin
26.7%
Operating Margin
15.7%
Net Margin
12.7%
ROE
15.7%
Debt / Equity
0.51x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.